Tag Archive for: OTC

Futura Medical Full Year Results for the year ended 31 December 2022

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain, is pleased to announce its audited results for the year ended 31 December 2022. Read more…

Futura provides US regulatory and commercial update for MED3000

Futura Medical plc (AIM: FUM), a pharmaceutical company developing a portfolio of innovative products for sexual health and pain relief, is pleased to provide an update on good progress with its regulatory and commercial activities for MED3000. MED3000 is the Company’s breakthrough, topical gel formulation for treatment of erectile dysfunction (“ED”).  It has the potential […]